Cuba spreads clinical trials of Heberprot-P in Russia

heberprot p

The clinical trials for the implementation of the Cuban biopharmaceutical drug Heberprot-P in patients with diabetic foot in Russia show today the effectiveness of the medicine, with prospects of being extended to a larger number of regions.

We move satisfactorily in the collaboration with the regions in the medical-pharmaceutical issue, specifically the introduction of Heberprot P in pilot studies, Cuban ambassador, Emilio Lozada, said in an interview with Prensa Latina.

Lozada recalled that the medicine, unique in the world prescribed for treating diabetic foot ulcer, was registered in Russia in February 2014, and then included in the list of Essential and Vital Medicines within the Federation, earlier this year.

Read more:


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s